India-made Covaxin now on United Kingdom’s approved travel list
Earlier this month, the Bharat Biotech manufactured Covaxin, the second most used formulation in India, had received its WHO EUL status
London: India's indigenously-made 'Covaxin', one of the vaccines being used nationwide in the inoculation campaign against the COVID-19 pandemic, is on the UK's list of approved COVID-19 vaccines for international travellers from Monday.
It will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms. Like other fully vaccinated travellers, including those vaccinated with Covishield, they are required to pre-book a PCR or Lateral Flow Test on arrival in England, to be taken before the end of day 2.
"From 4 am on Monday 22 November, the government will recognise vaccines on the World Health Organisation’s Emergency Use Listing (WHO EUL) at the border," the UK’s Department for Transport (DfT) confirmed.
"As a result, Sinovac, Sinopharm Beijing and Covaxin will be added to our existing list of approved vaccine for inbound travel, benefitting more fully vaccinated passengers,” it said.
Earlier this month, the Bharat Biotech manufactured Covaxin, the second most used formulation in India, had received its WHO EUL status, resulting in the UK announcing plans to include it on its list of approved COVID vaccines from 22 November.
The WHO Emergency Use Listing process includes a review of quality, safety and efficacy data performed by WHO experts, and many countries such as the United States, Spain, Sweden, Switzerland and Iceland recognise this categorisation.
Meanwhile, travellers who aren’t fully vaccinated against COVID-19 are required to undergo a pre-departure test and 10-day quarantine at a declared address in Britain.
From Monday, the UK government said it is also simplifying travel rules for all under-18s coming to England from a non-red-list country, who will be treated as fully vaccinated at the border, regardless of their individual vaccination status. This means they will be exempt from self-isolation requirements on arrival and will only be required to take a lateral flow test post-arrival, with a free confirmatory PCR test if they test positive.
While public health is a devolved matter, the government said it is working closely with the devolved administrations of Wales, Scotland and Northern Ireland to ensure a UK-wide approach to the rules.
Covaxin maker Bharat Biotech said that a study conducted at Emory University showed that subjects who received a booster shot six months after getting a primary two-dose series have witnessed neutralising of the Omicron and Delta variants
Is Centre giving ‘expired’ COVID-19 vaccines to teenagers? A look at the shelf life of a jab and what the row is about
The Centre on Monday issued a clarification, calling reports of expired Covaxin doses being administered to children aged 15-18 ‘misleading and false’
Based on emerging data, Bharat Biotech believes that a third dose may be beneficial to maintain the highest levels of protection and the dosage can be administered to adults and children alike